Immune Checkpoint Inhibitors Induced Hepatotoxicity; Gastroenterologists’ Perspectives

BACKGROUND: Immune checkpoint inhibitors (ICIs) have promising clinical activity and are essential medications for patients with several malignancies. However, by deranging the immune system, these novel agents could lead to immune-related adverse events (IRAEs). Hepatotoxicity with checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Farshidpour, Maham, Hutson, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489307/
https://www.ncbi.nlm.nih.gov/pubmed/36619143
http://dx.doi.org/10.34172/mejdd.2022.279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489307/
https://www.ncbi.nlm.nih.gov/pubmed/36619143
http://dx.doi.org/10.34172/mejdd.2022.279

Ejemplares similares